Gelest, Inc. joined The Antimicrobial Resistance (AMR) Challenge launched by the U.S. Government and CDC in September 2018. The AMR Challenge is an effort to accelerate the fight against antimicrobial resistance through committed action across governments and industries. Gelest manufactures BIOSAFEĀ® Antimicrobials that inhibit microorganism growth by physically puncturing the cell microbe membrane, killing the microbes on contact by electrocuting them.
HM4100 is polymeric powder that may be compounded into plastics, mixed into coatings, and dispersed in water.